The MMTV LTR adopts a specific nucleoprotein organization when introduced into cells. This structure involves the positioning of six nucleosomes (A-F) over the 1300 base pair LTR. A specific chromatin transition is induced by the binding of steroid receptors to the B nucleosome. By comparing the activity of transient MMTV reporter constructs (which are not organized in specific chromatin structures) with identical sequence elements that have replicated (and manifest the phased nucleosome array), we have shown that the chromatin transition is mechanistically important in transactivation, and that steroid receptors function on replicated genes by relieving chromatin repression. Our previous work showed that each phased nucleosome corresponds to a family of octamer cores positioned in that region. Thus, the low resolution phasing pattern results from the frequency- biased occupancy of a subset of these frames. We developed a new assay, the """"""""linked enzyme assay,"""""""" that permitted us to examine the nature of the nucleoprotein transition. We showed that the chromatin alteration does not correspond to a single nucleosome event, but is more accurately modeled as a higher order structure transition in a wrapped nucleosome array. Thus it is likely that steroid receptors interact with, and induced transitions in, 30 nanometer structures, rather than simple polynucleosome arrays. The mechanism of chromatin antirepression by receptors must be explored in the context of these findings. We also demonstrated that activation of the MMTV promoter is significantly modified when organized in this highly reproducible chromatin structure. Transiently introduced progesterone receptor was found to be incapable of activating the replicated structure, although quite active on transient, disorganized templates. In contrast, transiently introduced glucocorticoid receptor was functional on both transient and stable templates. These studies confirm that the organized nucleoprotein structure found on the MMTV LTR is functionally important in gene regulation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005450-14
Application #
6100809
Study Section
Special Emphasis Panel (LRBG)
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1998
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
John, Sam; Johnson, Thomas A; Sung, Myong-Hee et al. (2009) Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology 150:1766-74
Biddie, Simon C; Hager, Gordon L (2009) Glucocorticoid receptor dynamics and gene regulation. Stress 12:193-205
Hakim, Ofir; John, Sam; Ling, Jian Qun et al. (2009) Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions. J Biol Chem 284:6048-52
George, Anuja A; Schiltz, R Louis; Hager, Gordon L (2009) Dynamic access of the glucocorticoid receptor to response elements in chromatin. Int J Biochem Cell Biol 41:214-24
Johnson, Thomas A; Elbi, Cem; Parekh, Bhavin S et al. (2008) Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter. Mol Biol Cell 19:3308-22
Sung, Myong-Hee; Bagain, Lorena; Chen, Zhong et al. (2008) Dynamic effect of bortezomib on nuclear factor-kappaB activity and gene expression in tumor cells. Mol Pharmacol 74:1215-22
Klokk, Tove I; Kurys, Piotr; Elbi, Cem et al. (2007) Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol 27:1823-43
Hager, Gordon L; Elbi, Cem; Johnson, Thomas A et al. (2006) Chromatin dynamics and the evolution of alternate promoter states. Chromosome Res 14:107-16
Qiu, Yi; Zhao, Yingming; Becker, Matthias et al. (2006) HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell 22:669-79
Korkmaz, Ceren G; Korkmaz, Kemal S; Kurys, Piotr et al. (2005) Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene 24:4934-45

Showing the most recent 10 out of 26 publications